Table 2 The demographic and clinical features of study patients grouped into patients with and without a post-MI cardiovascular event.
With an in-hospital event (n = 66) | Without in-hospital event (n = 161) | p-value | ||
|---|---|---|---|---|
Males, n (%) | 38 (57.6) | 117 (72.7) | 0.02* | |
Age (years), median (IQR) | 64 (11) | 60 (15) | 0.003* | |
Hospitalization duration (days), median (IQR) | 7 (3) | 5 (2) | < 0.001* | |
Admission to PCI time (hours), median (IQR) | 1 (23.5) | 16 (23) | 0.055 | |
Systolic blood pressure (mmHG), median (IQR) | 126 (38) | 125 (21) | 0.81 | |
Diastolic blood pressure (mmHG), median (IQR) | 78 (19) | 80 (17) | 0.53 | |
SPO2 (%), median (IQR) | 96 (2) | 96 (3) | 0.003* | |
Heart rate, median (IQR) | 88 (28) | 79 (17) | < 0.001* | |
Height (cm), median (IQR) | 167 (11) | 169 (8) | 0.21 | |
Weight (kg), median (IQR) | 80 (19) | 76 (18) | 0.16 | |
Previous cardiovascular history | ||||
MI, n (%) | 25 (37.9) | 43 (26.7) | 0.09 | |
PCI, n (%) | 20 (30.3) | 33 (20.5) | 0.11 | |
Stroke, n (%) | 4 (6.1) | 6 (3.7) | 0.32 | |
AF, n (%) | 2 (3) | 2 (1.2) | 0.33 | |
HF, n (%) | 9 (13.6) | 3 (1.9) | < 0.001* | |
Hospitalization due to HF, n (%) | 1 (1.5) | 2 (1.2) | 0.64 | |
Valvular disease, n (%) | 3 (4.5) | 9 (5.6) | 0.52 | |
Cardiovascular risk factors | ||||
Diabetes, n (%) | 27 (40.9) | 55 (34.2) | 0.33 | |
Hypertension, n (%) | 51 (77.3) | 96 (59.6) | 0.01* | |
Dyslipidemia, n (%) | 29 (37.9) | 43 (26.7) | 0.09 | |
Smoking, n (%) | Non-smoker | 24 (36.4) | 76 (47.2) | 0.32 |
Former smoker | 14 (21.2) | 29 (18) | ||
Current smoker | 28 (42.4) | 56 (34.8) | ||
RBC, median (IQR) | 4.4 (0.88) | 4.56 (0.64) | 0.06 | |
Hemoglobin, median (IQR) | 12.7 (3) | 13.5 (1.8) | 0.04* | |
Hematocrit, median (IQR) | 39.45 (7.8) | 39 (5) | 0.274 | |
RDW, median (IQR) | 13.7 (1.6) | 13.3 (1.1) | 0.04* | |
WBC, median (IQR) | 8.8 (6) | 8.6 (3.6) | 0.29 | |
Platelets, median (IQR) | 207 (80) | 218 (64) | 0.26 | |
Na, median (IQR) | 139.5 (7.8) | 141 (5) | 0.66 | |
K, median (IQR) | 4.15 (0.7) | 4.3 (0.6) | 0.13 | |
Creatinine, median (IQR) | 1.3 (0.6) | 1.1 (0.3) | < 0.001* | |
Glucose, median (IQR) | 145 (116) | 124 (78) | 0.13 | |
CRP, median (IQR) | 8.75 (32.4) | 7.2 (4) | 0.001* | |
Ejection fraction, median (IQR) | 35 (15) | 45 (20) | < 0.001* | |
Culprit vessel, n (%) | LAD | 30 (45.5) | 55 (34.2) | 0.08 |
LCX | 2 (3) | 22 (13.6) | ||
RCA | 20 (30.3) | 50 (31.1) | ||
Multi-vessel disease | 14 (21.2) | 34 (21.1) | ||
TIMI-flow, n (%) | 0 | 35 (53.8) | 59 (37.1) | 0.07 |
1 | 4 (6.2) | 16 (10.1) | ||
2 | 7 (10.8) | 13 (8.2) | ||
3 | 19 (29.2) | 71 (44.6) | ||
GRACE score, median (IQR) | 140.25 (47.1) | 116.6 (36.4) | < 0.001* | |
Killip classification, n (%) | I | 33 (52.4) | 134 (92.4) | < 0.001* |
II | 18 (28.6) | 6 (4.1) | ||
III | 4 (6.3) | 3 (2.1) | ||
IV | 8 (12.7) | 2 (1.4) | ||
STEMI, n (%) | 48 (72.7) | 94 (58.4) | 0.04* | |
MI localization, n (%) | Anterior | 23 (48.9) | 40 (42.6) | 0.72 |
Inferior | 20 (42.6) | 43 (45.7) | ||
Others | 4 (8.5) | 11 (11.7) | ||
STEMI reperfusion type, n (%) | Non-reperfused | 9 (19.1) | 6 (6.5) | < 0.001* |
Primary PCI | 25 (53.2) | 45 (48.3) | ||
Successful thrombolysis | 8 (17) | 42 (45.2) | ||
Failed thrombolysis | 5 (10.6) | 0 (0) | ||
STOP-BANG score, median (IQR) | 5 (3) | 3 (2) | < 0.001* | |
STOP-BANG risk class, n (%) | Low | 12 (18.2) | 45 (28) | 0.30 |
Intermediate | 4 (6.1) | 9 (5.6) | ||
High | 50 (75.8) | 107 (66.5) | ||
